Literature DB >> 32308197

Increased expression of microRNA-155-5p by alveolar type II cells contributes to development of lethal ARDS in H1N1 influenza A virus-infected mice.

Parker S Woods1, Lauren M Doolittle1, Lucia E Rosas1, S Patrick Nana-Sinkam2, Esmerina Tili3, Ian C Davis4.   

Abstract

Alveolar type II (ATII) cells are essential to lung function and a primary site of influenza A virus (IAV) replication. Effects of IAV infection on ATII cell microRNA (miR) expression have not been comprehensively investigated. Infection of C57BL/6 mice with 10,000 or 100 pfu/mouse of IAV A/WSN/33 (H1N1) significantly altered expression of 73 out of 1908 mature murine miRs in ATII cells at 2 days post-infection (d.p.i.) and 253 miRs at 6 d.p.i. miR-155-5p (miR-155) showed the greatest increase in expression within ATII cells at both timepoints and the magnitude of this increase correlated with inoculum size and pulmonary edema severity. Influenza-induced lung injury was attenuated in C57BL/6-congenic miR-155-knockout mice without affecting viral replication. Attenuation of lung injury was dependent on deletion of miR-155 from stromal cells and was recapitulated in ATII cell-specific miR-155-knockout mice. These data suggest that ATII cell miR-155 is a potential therapeutic target for IAV-induced ARDS.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Acute respiratory distress syndrome; Alveolar type II cell; Influenza A virus; Mouse; microRNA

Mesh:

Substances:

Year:  2020        PMID: 32308197      PMCID: PMC7199462          DOI: 10.1016/j.virol.2020.03.005

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.513


  47 in total

1.  Lung microRNA: from development to disease.

Authors:  Serge Patrick Nana-Sinkam; Todd Karsies; Brent Riscili; Michael Ezzie; Melissa Piper
Journal:  Expert Rev Respir Med       Date:  2009-08       Impact factor: 3.772

2.  MicroRNA-155 is induced during the macrophage inflammatory response.

Authors:  Ryan M O'Connell; Konstantin D Taganov; Mark P Boldin; Genhong Cheng; David Baltimore
Journal:  Proc Natl Acad Sci U S A       Date:  2007-01-22       Impact factor: 11.205

Review 3.  Biology of alveolar type II cells.

Authors:  Robert J Mason
Journal:  Respirology       Date:  2006-01       Impact factor: 6.424

4.  MicroRNA expression in mice infected with seasonal H1N1, swine H1N1 or highly pathogenic H5N1.

Authors:  Eric M Vela; Manjula D Kasoji; Morgan Q Wendling; Jennifer A Price; Katherine A B Knostman; Herbert S Bresler; James P Long
Journal:  J Med Microbiol       Date:  2014-06-09       Impact factor: 2.472

5.  Identification of Host Kinase Genes Required for Influenza Virus Replication and the Regulatory Role of MicroRNAs.

Authors:  Abhijeet Bakre; Lauren E Andersen; Victoria Meliopoulos; Keegan Coleman; Xiuzhen Yan; Paula Brooks; Jackelyn Crabtree; S Mark Tompkins; Ralph A Tripp
Journal:  PLoS One       Date:  2013-06-21       Impact factor: 3.240

6.  Infection of mice with influenza A/WSN/33 (H1N1) virus alters alveolar type II cell phenotype.

Authors:  Christian C Hofer; Parker S Woods; Ian C Davis
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2015-01-16       Impact factor: 6.011

7.  Lethal H1N1 influenza A virus infection alters the murine alveolar type II cell surfactant lipidome.

Authors:  Parker S Woods; Lauren M Doolittle; Lucia E Rosas; Lisa M Joseph; Edward P Calomeni; Ian C Davis
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2016-11-11       Impact factor: 6.011

8.  Human alveolar epithelial type II cells in primary culture.

Authors:  Pu Mao; Songling Wu; Jianchun Li; Wei Fu; Weiqun He; Xiaoqing Liu; Arthur S Slutsky; Haibo Zhang; Yimin Li
Journal:  Physiol Rep       Date:  2015-02-12

9.  microRNA-155 regulates the generation of immunoglobulin class-switched plasma cells.

Authors:  Elena Vigorito; Kerry L Perks; Cei Abreu-Goodger; Sam Bunting; Zou Xiang; Susan Kohlhaas; Partha P Das; Eric A Miska; Antony Rodriguez; Allan Bradley; Kenneth G C Smith; Cristina Rada; Anton J Enright; Kai-Michael Toellner; Ian C M Maclennan; Martin Turner
Journal:  Immunity       Date:  2007-12-06       Impact factor: 31.745

10.  MicroRNA expression profile of mouse lung infected with 2009 pandemic H1N1 influenza virus.

Authors:  Zhihao Wu; Rongzhang Hao; Peng Li; Xiaoai Zhang; Nan Liu; Shaofu Qiu; Ligui Wang; Yong Wang; Wenzhong Xue; Kun Liu; Guang Yang; Jiajun Cui; Chuanfu Zhang; Hongbin Song
Journal:  PLoS One       Date:  2013-09-16       Impact factor: 3.240

View more
  10 in total

1.  GATA3 Inhibits Viral Infection by Promoting MicroRNA-155 Expression.

Authors:  Jiaxin Li; Areayi Haiyilati; Linyi Zhou; Juncheng Chen; Yongqiang Wang; Li Gao; Hong Cao; Xiaoqi Li; Shijun J Zheng
Journal:  J Virol       Date:  2022-03-23       Impact factor: 6.549

2.  Cytidine 5'-Diphosphocholine Corrects Alveolar Type II Cell Mitochondrial Dysfunction in Influenza-infected Mice.

Authors:  Lauren M Doolittle; Katherine Binzel; Katherine E Nolan; Kelsey Craig; Lucia E Rosas; Matthew C Bernier; Lisa M Joseph; Parker S Woods; Michael V Knopp; Ian C Davis
Journal:  Am J Respir Cell Mol Biol       Date:  2022-06       Impact factor: 7.748

3.  The expression patterns of MALAT-1, NEAT-1, THRIL, and miR-155-5p in the acute to the post-acute phase of COVID-19 disease.

Authors:  Mohammad Abbasi-Kolli; Javid Sadri Nahand; Seyed Jalal Kiani; Khadijeh Khanaliha; AliReza Khatami; Mohammad Taghizadieh; Ali Rajabi Torkamani; Kimiya Babakhaniyan; Farah Bokharaei-Salim
Journal:  Braz J Infect Dis       Date:  2022-04-25       Impact factor: 3.257

4.  Transcriptomic profiling of SARS-CoV-2 infected human cell lines identifies HSP90 as target for COVID-19 therapy.

Authors:  Emanuel Wyler; Kirstin Mösbauer; Vedran Franke; Asija Diag; Lina Theresa Gottula; Roberto Arsiè; Filippos Klironomos; David Koppstein; Katja Hönzke; Salah Ayoub; Christopher Buccitelli; Karen Hoffmann; Anja Richter; Ivano Legnini; Andranik Ivanov; Tommaso Mari; Simone Del Giudice; Jan Papies; Samantha Praktiknjo; Thomas F Meyer; Marcel Alexander Müller; Daniela Niemeyer; Andreas Hocke; Matthias Selbach; Altuna Akalin; Nikolaus Rajewsky; Christian Drosten; Markus Landthaler
Journal:  iScience       Date:  2021-02-06

5.  Versatile and flexible microfluidic qPCR test for high-throughput SARS-CoV-2 and cellular response detection in nasopharyngeal swab samples.

Authors:  Julien Fassy; Caroline Lacoux; Sylvie Leroy; Latifa Noussair; Sylvain Hubac; Aurélien Degoutte; Georges Vassaux; Vianney Leclercq; David Rouquié; Charles-Hugo Marquette; Martin Rottman; Patrick Touron; Antoinette Lemoine; Jean-Louis Herrmann; Pascal Barbry; Jean-Louis Nahon; Laure-Emmanuelle Zaragosi; Bernard Mari
Journal:  PLoS One       Date:  2021-04-14       Impact factor: 3.240

6.  Acute and post-acute phase of COVID-19: Analyzing expression patterns of miRNA-29a-3p, 146a-3p, 155-5p, and let-7b-3p in PBMC.

Authors:  Tahereh Donyavi; Farah Bokharaei-Salim; Hossein Bannazadeh Baghi; Khadijeh Khanaliha; Mahrokh Alaei Janat-Makan; Bahareh Karimi; Javid Sadri Nahand; Hamed Mirzaei; AliReza Khatami; Saba Garshasbi; Majid Khoshmirsafa; Seyed Jalal Kiani
Journal:  Int Immunopharmacol       Date:  2021-04-06       Impact factor: 5.714

Review 7.  The role of microRNAs in solving COVID-19 puzzle from infection to therapeutics: A mini-review.

Authors:  Sujay Paul; Luis Alberto Bravo Vázquez; Paula Roxana Reyes-Pérez; Carolina Estrada-Meza; Rafael Arturo Aponte Alburquerque; Surajit Pathak; Antara Banerjee; Anindya Bandyopadhyay; Samik Chakraborty; Aashish Srivastava
Journal:  Virus Res       Date:  2021-11-14       Impact factor: 3.303

Review 8.  miRNAs, from Evolutionary Junk to Possible Prognostic Markers and Therapeutic Targets in COVID-19.

Authors:  Brandon Bautista-Becerril; Guillermo Pérez-Dimas; Paola C Sommerhalder-Nava; Alejandro Hanono; Julio A Martínez-Cisneros; Bárbara Zarate-Maldonado; Evangelina Muñoz-Soria; Arnoldo Aquino-Gálvez; Manuel Castillejos-López; Armida Juárez-Cisneros; Jose S Lopez-Gonzalez; Angel Camarena
Journal:  Viruses       Date:  2021-12-27       Impact factor: 5.048

Review 9.  Host Non-Coding RNA Regulates Influenza A Virus Replication.

Authors:  Yuejiao Liao; Shouqing Guo; Geng Liu; Zhenyu Qiu; Jiamin Wang; Di Yang; Xiaojing Tian; Ziling Qiao; Zhongren Ma; Zhenbin Liu
Journal:  Viruses       Date:  2021-12-29       Impact factor: 5.048

10.  MicroRNAs based regulation of cytokine regulating immune expressed genes and their transcription factors in COVID-19.

Authors:  Manoj Khokhar; Sojit Tomo; Purvi Purohit
Journal:  Meta Gene       Date:  2021-10-26
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.